Revive Therapeutics Ltd. Announces Encouraging Interim Results From Ongoing …

Published February 24, 2014

Revive Therapeutics Ltd. Announces Encouraging Interim Results from Ongoing …
"I am pleased to see that REV-001 has shown initial clinical response signals as we continue to advance the clinical development of this compound for the prevention of opioid-induced respiratory depression in an acute setting," said Fabio Chianelli … Read more on Marketwired (press release)

Verdict Mixed on Autism Link to SSRI Use in Pregnancy
Information about whether the children's mothers had been treated for depression during pregnancy was available from inpatient and outpatient psychiatric records, and information about whether the mothers had used antidepressants during pregnancy was … Read more on Psychiatric News